Home › Islet Cell Adenoma › Pennsylvania
Islet Cell Adenoma clinical trials in Pennsylvania
4 studies for Islet Cell Adenoma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06943755Nutrition Intervention for Pancreatic Cancer
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania Abramson Cancer Center, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT07554560Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT05477576Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT05040360From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.